Atea Historical Balance Sheet
AVIR Stock | USD 3.67 0.06 1.66% |
Trend analysis of Atea PharmaceuticalsInc balance sheet accounts such as Other Current Liab of 20.6 M, Total Current Liabilities of 57 M or Total Stockholder Equity of 434.1 M provides information on Atea PharmaceuticalsI's total assets, liabilities, and equity, which is the actual value of Atea PharmaceuticalsInc to its prevalent stockholders. By breaking down trends over time using Atea PharmaceuticalsI balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Atea PharmaceuticalsInc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Atea PharmaceuticalsInc is a good buy for the upcoming year.
Atea |
About Atea Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Atea PharmaceuticalsInc at a specified time, usually calculated after every quarter, six months, or one year. Atea PharmaceuticalsI Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Atea PharmaceuticalsI and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Atea currently owns. An asset can also be divided into two categories, current and non-current.
Atea PharmaceuticalsI Balance Sheet Chart
Atea PharmaceuticalsI Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Atea PharmaceuticalsInc uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Atea PharmaceuticalsI's Property Plant And Equipment Gross is relatively stable compared to the past year. As of 06/03/2024, Accumulated Other Comprehensive Income is likely to grow to about 217.3 K, while Other Current Liabilities is likely to drop slightly above 20.6 M. Add Fundamental
Total Assets
Total assets refers to the total amount of Atea PharmaceuticalsI assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Atea PharmaceuticalsInc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Atea PharmaceuticalsI balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Atea PharmaceuticalsInc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Short Term Investments
Short Term Investments is an item under the current assets section of Atea PharmaceuticalsI balance sheet. It contains any investments Atea PharmaceuticalsInc undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Atea PharmaceuticalsInc can easily liquidate in the marketplace.Most accounts from Atea PharmaceuticalsI's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Atea PharmaceuticalsInc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atea PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. At this time, Atea PharmaceuticalsI's Property Plant And Equipment Gross is relatively stable compared to the past year. As of 06/03/2024, Accumulated Other Comprehensive Income is likely to grow to about 217.3 K, while Other Current Liabilities is likely to drop slightly above 20.6 M.
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 52.3M | 15.2M | 27.4M | 20.6M | Total Assets | 772.9M | 666.7M | 595.0M | 541.8M |
Atea PharmaceuticalsI balance sheet Correlations
Click cells to compare fundamentals
Atea PharmaceuticalsI Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Atea PharmaceuticalsI balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 22.1M | 863.6M | 772.9M | 666.7M | 595.0M | 541.8M | |
Other Current Liab | 1.9M | 14.4M | 52.3M | 15.2M | 27.4M | 20.6M | |
Total Current Liabilities | 2.4M | 315.8M | 56.9M | 18.5M | 32.4M | 57.0M | |
Total Stockholder Equity | (49.6M) | 547.8M | 710.1M | 640.6M | 555.2M | 434.1M | |
Other Liab | 95K | 36K | 5.9M | 5.3M | 6.0M | 6.3M | |
Net Tangible Assets | (49.6M) | 547.8M | 710.1M | 640.6M | 736.7M | 398.8M | |
Property Plant And Equipment Net | 41K | 48K | 23K | 4.1M | 3.1M | 3.3M | |
Net Debt | (21.7M) | (850.1M) | (764.2M) | (643.6M) | (141.4M) | (148.5M) | |
Retained Earnings | (54.2M) | (65.2M) | 56.0M | (59.9M) | (195.8M) | (186.0M) | |
Accounts Payable | 548K | 60K | 4.5M | 2.6M | 4.3M | 2.3M | |
Cash | 21.7M | 850.1M | 764.4M | 646.7M | 143.8M | 136.6M | |
Cash And Short Term Investments | 21.7M | 850.1M | 764.4M | 646.7M | 578.1M | 530.8M | |
Common Stock Shares Outstanding | 82.6M | 82.4M | 88.2M | 83.2M | 83.4M | 85.7M | |
Liabilities And Stockholders Equity | 22.1M | 863.6M | 772.9M | 666.7M | 595.0M | 541.8M | |
Non Current Liabilities Total | 69.2M | 36K | 5.9M | 7.7M | 7.4M | 7.0M | |
Other Current Assets | 249K | 7.5M | 8.0M | 14.2M | 12.3M | 7.8M | |
Other Stockholder Equity | 4.6M | 612.9M | 654.0M | 701.1M | 750.7M | 500.0M | |
Total Liab | 71.6M | 315.8M | 62.8M | 26.1M | 39.8M | 78.3M | |
Net Invested Capital | (49.6M) | 547.8M | 710.1M | 640.6M | 555.2M | 434.1M | |
Property Plant And Equipment Gross | 41K | 48K | 184K | 4.4M | 3.8M | 4.0M | |
Total Current Assets | 21.9M | 863.5M | 772.4M | 660.9M | 590.5M | 539.7M | |
Accumulated Other Comprehensive Income | (69.1M) | (863.6M) | 0.0 | (684K) | 207K | 217.4K | |
Net Working Capital | 19.5M | 547.7M | 715.5M | 642.4M | 558.1M | 461.3M | |
Property Plant Equipment | 41K | 48K | 23K | 4.1M | 4.7M | 4.9M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atea PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Atea Stock analysis
When running Atea PharmaceuticalsI's price analysis, check to measure Atea PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea PharmaceuticalsI is operating at the current time. Most of Atea PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Atea PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Atea PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |
Is Atea PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atea PharmaceuticalsI. If investors know Atea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atea PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.641 | Earnings Share (1.95) | Revenue Per Share 2.31 | Quarterly Revenue Growth 2.952 | Return On Assets (0.16) |
The market value of Atea PharmaceuticalsInc is measured differently than its book value, which is the value of Atea that is recorded on the company's balance sheet. Investors also form their own opinion of Atea PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Atea PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Atea PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Atea PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.